InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Thursday, 09/06/2018 7:21:08 AM

Thursday, September 06, 2018 7:21:08 AM

Post# of 345783
The hepatocellular carcinoma market | Nature Reviews Drug ...
https://www.nature.com › ... › article

vor 6 Tagen · ... ramucirumab or sorafenib, and the phosphatidylserine-targeted mAb bavituximab (Oncologie) with pembrolizumab

https://www.nature.com/articles/nrd.2018.146

Maybe it's better to buy 10 CDMO instead this article - IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News